Professor of Psychiatry, UCLA
Psychiatry
Dr. Michael J. Gitlin, MD
|
|
Give Review
Michael Gitlin is an expert in the field of Psychiatry. He went to medical school at Perelman School of Medicine at the University of Pennsylvania. He received 5 awards: "America's Top Doctors", "Top Doctors:LA Area", "Top Doctors:Southern California", "Super Doctor" and "Top MD". Michael Gitlin is a published doctor. He has 97 papers published. The most current publication "Suicidal ideation and suicide attempts in recent-onset schizophrenia."
Publications
- Predictors of depression outcomes among abstinent methamphetamine-dependent individuals exposed to an exercise intervention.
- Negative symptoms and functioning during the first year after a recent onset of schizophrenia and 8years later.
- Suicidal ideation and behavior associated with antidepressant medications: Implications for the treatment of chronic pain.
- Psychiatric diagnosis in ICD-11: Lessons learned (or not) from the mood Disorders section in DSM-5.
- Lamotrigine in psychiatric Disorders.
- Suicidality associated with antiepileptic drugs: Implications for the treatment of neuropathic pain and fibromyalgia.
- Maintenance therapies in Bipolar disorders.
- The clinical management of Bipolar disorder complexity using a stratified model.
- Neurocognitive predictors of work outcome in recent-onset schizophrenia.
- Remission and recovery during the first outpatient year of the early course of schizophrenia.
- Risperidone nonadherence and return of positive symptoms in the early course of schizophrenia.
- Ziprasidone, monoamine oxidase inhibitors, and the serotonin syndrome.
- Subsyndromal Depressive symptoms after symptomatic recovery from mania are associated with delayed functional recovery.
- Augmentation strategies in the treatment of major depressive Disorder. Clinical considerations with atypical antipsychotic augmentation.
- Lack of mania prophylaxis associated with lamotrigine monotherapy in manic-predominant Bipolar I disorder.
- Increased suicidality in mania complicated by alcoholism.
- Placebo response in clinical trials of depression and its implications for research on chronic neuropathic pain.
- Electrodermal predictors of functional outcome and negative symptoms in schizophrenia.
- Unmet needs in Bipolar depression.
- Intra- and interindividual variations in steady-state plasma concentrations of risperidone and 9-hydroxyrisperidone in schizophrenic patients treated chronically with ...
- Acceleration and augmentation strategies for treating Bipolar depression.
- Treating acute mania.
- Subsyndromal depression is associated with functional impairment in patients with Bipolar disorder.
- Bupropion-sustained release as a treatment for SSRI-induced sexual side effects.
- In vivo evidence of differential impact of typical and atypical antipsychotics on intracortical myelin in adults with schizophrenia.
- Improving the design of maintenance studies for Bipolar disorder.
- Classifying episodes in schizophrenia and Bipolar disorder: criteria for relapse and remission applied to recent-onset samples.
- Patterns of alcohol consumption in Bipolar patients comorbid for alcohol abuse or dependence.
- Self-efficacy and neurocognition may be related to coping responses in recent-onset schizophrenia.
- Clinical outcome following neuroleptic discontinuation in patients with remitted recent-onset schizophrenia.
- Suicidal ideation and suicide attempts in recent-onset schizophrenia.
- Efficacy and response time to sertraline versus fluoxetine in the treatment of unipolar major depressive Disorder.
- Gabapentin in the acute treatment of refractory Bipolar disorder.
- The impact of antidepressant discontinuation versus antidepressant continuation on 1-year risk for relapse of Bipolar depression: a retrospective chart review.
- Differential effects of typical and atypical antipsychotics on brain myelination in schizophrenia.
- Stressful life events predict delayed functional recovery following treatment for mania in Bipolar disorder.
- Bipolar depression and antidepressant-induced mania: a naturalistic study.
- Relapse and impairment in Bipolar disorder.
- Stress reactivity in Bipolar patients and its relation to prior history of disorder.
- Life events and the course of Bipolar disorder.
- Developmental Processes in Schizophrenic Disorders: longitudinal studies of vulnerability and stress.
- Fluphenazine levels during maintenance treatment of recent-onset schizophrenia: relation to side effects, psychosocial function and depression.
- The effect of previous Mood states on switch rates: a naturalistic study.
- Dysregulated brain development in adult men with schizophrenia: a magnetic resonance imaging study.
- Gender and Bipolar illness.
- The impact of neurocognitive impairment on occupational recovery of clinically stable patients with Bipolar disorder: a prospective study.
- Does thyroid supplementation accelerate tricyclic antidepressant response? A review and meta-analysis of the literature.
- The early course of schizophrenia and long-term maintenance neuroleptic therapy.
- Peripheral thyroid hormones and response to selective serotonin reuptake inhibitors.
- Predictors of work adjustment in Bipolar I patients: a naturalistic longitudinal follow-up.
- Correlates of stress reactivity in patients with Bipolar disorder.
- Maintenance lithium treatment: side effects and compliance.
- Free T4 index and clinical outcome in patients with depression.
- Life events and schizophrenic relapse after withdrawal of medication.
- The vulnerability/stress model of schizophrenic relapse: a longitudinal study.
- Expressed emotion, fixed-dose fluphenazine decanoate maintenance, and relapse in recent-onset schizophrenia.
- Communication deviance in families of schizophrenic and manic patients.
- Persistence of fluphenazine in plasma after decanoate withdrawal.
- Treatment-resistant Bipolar disorder.
- Unanswered questions, unknown future for one of our oldest medications.
- Dexamethasone suppression test and treatment response.
- Failure of T3 to potentiate tricyclic antidepressant response.
- Venlafaxine, monoamine oxidase inhibitors, and the serotonin syndrome.
- Sociotropy/autonomy and vulnerability to specific life events in patients with unipolar depression and Bipolar disorders.
- Treatment of sexual side effects with dopaminergic agents.
- Sweets, chocolate, and atypical Depressive traits.
- Bupropion-tranylcypromine combination for treatment-refractory depression.
- Verapamil as maintenance treatment in Bipolar illness: a case report.
- Psychotropic medications and their effects on sexual function: diagnosis, biology, and treatment approaches.
- Autonomic abnormalities in schizophrenia. State or trait indicators?
- A psychiatrist's reaction to a patient's suicide.
- Pharmacologic management of psychiatric illness during pregnancy: dilemmas and guidelines.
- Inpatient treatment of depression and associated hospital charges.
- Clinical aspects of depression in chronic pain patients.
- Psychiatric syndromes linked to reproductive function in women: a review of current knowledge.
- New antidepressants and the treatment of depression.
- Antidepressant medications, Mood and male fertility.
- Psychiatric history and stress: predictors of severity of unipolar depression.
- Lithium-induced renal insufficiency.
- Lithium and the kidney: an updated review.
- Bipolar disorder: current clinical research trends.
- Sexual dysfunction with psychotropic drugs.
- Irresistible joys and discouraging pitfalls in diagnosing personality Disorders.
- The neuropathologic basis of major affective Disorders: neuroanatomic insights.
- Effects of depression and antidepressants on sexual functioning.
- Pharmacotherapy of personality Disorders: conceptual framework and clinical strategies.
- Verapamil in treatment-resistant mania: an open trial.
- Lithium clinics: theory and practice.
- Desipramine and methylphenidate combination treatment for depression: case report.
- L-triiodothyronine-precipitated angina and clinical response.
- The dexamethasone suppression test and response to somatic treatment: a review.
- Lithium: serum levels, renal effects, and dosing strategies.
- Attitudinal correlates of lithium compliance in Bipolar affective disorders.
- Possible withdrawal from endogeneous opiates in schizophrenics.
- Questioning a contraindication of propranolol.
- Reported weight loss and dexamethasone nonsuppression in depressed patients. A negative study.
Schools
Perelman School of Medicine University of Pennsylvania
Presby Penn Med Center
University Of California Los Angeles
Procedures Preformed
- Group Psychotherapy
Conditions Treated
- Bipolar Disorder
- Dysthymia and Cyclothymia (Mood Disorders)
- Major Depressive Disorder
- Schizophreniform and Schizoaffective Disorder
Doctors Specialties
- Psychiatry
Accepted Insurances
Awards
- America's Top Doctors
- Top Doctors:LA Area
- Top Doctors:Southern California
- Super Doctor
- Top MD
Education
-
UCLA Neuropsychiatric Hospital -
University of Pennsylvania -
Perelman School of Medicine at the University of Pennsylvania
Hospital
-
Ronald Reagan UCLA Medical Center
Drug Facts
| NPI NUMBER | 1821018086 | |
| NPPES Provider LastName | GITLIN | |
| NPPES Provider FirstName | MICHAEL | |
| NPPES Provider ZIPCode | 900958353 | |
| NPPES Provider State | CA | |
| Specialty Description | Psychiatry | |
| Total Claim Count | 556.0 | |
| Distinct Opioid Count | 0.0 | |
| Opioid Claim Count | 0.0 | |
| Percent Opioid Claims | 0.0 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1821018086 |
| Last Name Of The Provider | GITLIN |
| First Name Of The Provider | MICHAEL |
| View All |
Similar Doctors
|
|
Dr. Thomas E. Hoffman, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Rochelle J. Woods, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Maurice Weise, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Eric Chaghouri, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Martin V. Cohen, PHD |
|
|
Dr. Benjamin N. Schneider, MD |
|
|
Dr. Chandresh M. Shah, MD
This Doctor is OpenDoctor Recommended.
|